Your browser doesn't support javascript.
loading
Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions.
Pignatti, F; Ashby, D; Brass, E P; Eichler, H-G; Frey, P; Hillege, H L; Hori, A; Levitan, B; Liberti, L; Löfstedt, R E; McAuslane, N; Micaleff, A; Noel, R A; Postmus, D; Renn, O; Sabourin, B J; Salmonson, T; Walker, S.
Afiliación
  • Pignatti F; The European Medicines Agency, London, United Kingdom.
  • Ashby D; School of Public Health, Imperial College London, London, United Kingdom.
  • Brass EP; Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
  • Eichler HG; The European Medicines Agency, London, United Kingdom.
  • Frey P; Food and Drug Administration, Silver Spring, Maryland, USA.
  • Hillege HL; University of Groningen, Groningen, The Netherlands.
  • Hori A; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Levitan B; Janssen Pharmaceutical Research and Development, Titusville, New Jersey, USA.
  • Liberti L; Centre for Innovation in Regulatory Science (CIRS), London, United Kingdom.
  • Löfstedt RE; Risk Research Group, Centre for Environmental Strategy, University of Surrey, Guildford, United Kingdom.
  • McAuslane N; Centre for Innovation in Regulatory Science (CIRS), London, United Kingdom.
  • Micaleff A; Merck Serono, Geneva, Switzerland.
  • Noel RA; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Postmus D; The European Medicines Agency, London, United Kingdom.
  • Renn O; Institut für Sozialwissenschaften, Universität Stuttgart, Stuttgart, Germany.
  • Sabourin BJ; Health Canada, Ottawa, Ontario, Canada.
  • Salmonson T; Läkemedelsverket, Uppsala, Sweden.
  • Walker S; Centre for Innovation in Regulatory Science (CIRS), London, United Kingdom.
Clin Pharmacol Ther ; 98(5): 522-33, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26261064
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: United States Food and Drug Administration / Comunicación / Medición de Riesgo / Agencias Gubernamentales Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte / Europa Idioma: En Revista: Clin Pharmacol Ther Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: United States Food and Drug Administration / Comunicación / Medición de Riesgo / Agencias Gubernamentales Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte / Europa Idioma: En Revista: Clin Pharmacol Ther Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido